Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-65,515
Closed -$29.6K 727
2025
Q2
$29.6K Sell
65,515
-833
-1% -$362 ﹤0.01% 661
2025
Q1
$27K Hold
66,348
﹤0.01% 476
2024
Q4
$43.9K Hold
66,348
﹤0.01% 512
2024
Q3
$56.3K Hold
66,348
﹤0.01% 539
2024
Q2
$44.3K Buy
66,348
+5,252
+9% +$4.36K ﹤0.01% 524
2024
Q1
$79.4K Buy
61,096
+3,000
+5% +$3.14K ﹤0.01% 558
2023
Q4
$33.3K Sell
58,096
-1,900
-3% -$1.31K ﹤0.01% 502
2023
Q3
$45.2K Buy
59,996
+7,600
+15% +$5.78K ﹤0.01% 494
2023
Q2
$38.2K Buy
52,396
+4,640
+10% +$4.31K ﹤0.01% 502
2023
Q1
$36.1K Buy
47,756
+6,055
+15% +$5.62K ﹤0.01% 480
2022
Q4
$40.1K Buy
+41,701
New +$58.9K ﹤0.01% 462

Other funds holding VXRT

Curi RMB Capital's VXRT Position: Q3 2025 in Review

Curi RMB Capital sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 65,515 shares — an estimated $29.6K sold.

Curi RMB Capital first reported a position in VXRT in Q4 2022 and held it in 11 quarters. The position peaked at $79.4K in Q1 2024. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Curi RMB Capital reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Curi RMB Capital sold 65,515 Vaxart shares in Q3 2025, an estimated $29.6K.
  • Curi RMB Capital first reported a position in Vaxart in Q4 2022 and held it in 11 quarters.
  • Curi RMB Capital's Vaxart position peaked at $79.4K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Curi RMB Capital's 13F filing for Q3 2025, filed 13 Nov 2025.